Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Gross Margin (2018 - 2025)

Selectis Health's Gross Margin history spans 8 years, with the latest figure at 27.61% for Q4 2025.

  • Quarterly results put Gross Margin at 27.61% for Q4 2025, up 327.0% from a year ago — trailing twelve months through Dec 2025 was 23.36% (up 24.0% YoY), and the annual figure for FY2025 was 23.36%, up 24.0%.
  • Gross Margin for Q4 2025 was 27.61% at Selectis Health, up from 21.41% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 39.69% in Q3 2021 to a low of 11.41% in Q1 2023.
  • The 5-year median for Gross Margin is 22.6% (2021), against an average of 23.66%.
  • The sharpest move saw Gross Margin plummeted -2570bps in 2021, then skyrocketed 1635bps in 2022.
  • Year by year, Gross Margin stood at 13.08% in 2021, then surged by 51bps to 19.75% in 2022, then decreased by -20bps to 15.87% in 2023, then soared by 53bps to 24.34% in 2024, then increased by 13bps to 27.61% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 27.61%, 21.41%, and 21.89% for Q4 2025, Q3 2025, and Q2 2025 respectively.